Abstract
Thermal ablative techniques have been increasingly recognized as a valuable alternative to graftectomy and nephron-sparing surgery for the treatment of small neoplasms arising in the transplanted kidney. However, long-term efficacy and safety data are still lacking. In particular, current experience with microwave ablation is limited to a very recent single-centre series of three cases. We herein report two microwave ablations of renal cell carcinoma of the kidney allograft. The procedures were successfully performed under ultrasound guidance with complete tumour necrosis, no peri-operative complications, and preserved renal function. No recurrences were observed after 3 years of follow-up.
Similar content being viewed by others
References
Au EH, Chapman JR, Craig JC, Lim WH, Teixeira-Pinto A, Ullah S, McDonald S, Wong G. Overall and site-specific cancer mortality in patients on dialysis and after kidney transplant. J Am Soc Nephrol. 2019;30(3):471–80.
Griffith JJ, Amin KA, Waingankar N, Lerner SM, Delaney V, Ames SA, Badani K, Palese MA, Mehrazin R. Solid renal masses in transplanted allograft kidneys: a closer look at the epidemiology and management. Am J Transplant. 2017;17(11):2775–811.
Rao PS, Schaubel DE, Jia X, Li S, Port FK, Saran R. Survival on dialysis post-kidney transplant failure: results from the Scientific Registry of Transplant Recipients. Am J Kidney Dis. 2007;49(2):294–300.
Tillou X, Guleryuz K, Collon S, Doerfler A. Renal cell carcinoma in functional renal graft: toward ablative treatments. Transplant Rev (Orlando). 2016;30(1):20–6.
Gul ZG, Griffith JJ, Welch C, Fischman A, Palese MA, Badani KK, Mehrazin R. Focal ablative therapy for renal cell carcinoma in transplant allograft kidneys. Urology. 2019;125:118–22.
Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 2009; 182(3):844–853.
Schmit GD, Kurup AN, Weisbrod AJ, Thompson RH, Boorjian SA, Wass CT, Callstrom MR, Atwell TD. ABLATE: a renal ablation planning algorithm. AJR Am J Roentgenol. 2014;202(4):894–903.
Tillou X, Doerfler A, Collon S, Kleinclauss F, Patard JJ, Badet L, Barrou B, Audet M, Bensadoun H, Berthoux E, Bigot P, Boutin JM, Bouzguenda Y, Chambade D, Codas R, Dantal J, Deturmeny J, Devonec M, Dugardin F, Ferrière JM, Erauso A, Feuillu B, Gigante M, Guy L, Karam G, Lebret T, Neuzillet Y, Legendre C, Perez T, Rerolle JP, Salomon L, Sallusto F, Sénéchal C, Terrier N, Thuret R, Verhoest G, Petit J, Comité de Transplantation de l’Association Française d’Urologie (CTAFU). De novo kidney graft tumors: results from a multicentric retrospective national study. Am J Transplant. 2012;12(12):3308–15.
Diller R, Senninger N. Treatment options and outcome for renal cell tumors in the transplanted kidney. Int J Artif Organs. 2008;31(10):867–74.
Viart L, Surga N, Collon S, Jaureguy M, Elalouf V, Tillou X. The high rate of de novo graft carcinomas in renal transplant recipients. Am J Nephrol. 2013;37(2):91–6.
Hinshaw JL, Lubner MG, Ziemlewicz TJ, Lee FT, Brace CL. Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation—what should you use and why? Radiographics. 2014;34(5):1344–62.
Seror O. Ablative therapies: Advantages and disadvantages of radiofrequency, cryotherapy, microwave and electroporation methods, or how to choose the right method for an individual patient? Diagn Interv Imaging. 2015;96(6):617–24.
Cornelis FH, Marcelin C, Bernhard JC. Microwave ablation of renal tumors: a narrative review of technical considerations and clinical results. Diagn Interv Imaging. 2017;98(4):287–97.
Gervais DA. Cryoablation versus radiofrequency ablation for renal tumor ablation: time to reassess? J Vasc Interv Radiol. 2013;24(8):1135–8.
Shakeri S, Afshari Mirak S, Mohammadian Bajgiran A, Pantuck A, Sisk A, Ahuja P, Lu DS, Raman SS. The effect of tumor size and location on efficacy and safety of US- and CT-guided percutaneous microwave ablation in renal cell carcinomas. Abdom Radiol (NY). 2019;44(6):2308–15.
Su MZ, Campbell NA, Lau HM. Management of renal masses in transplant allografts at an Australian kidney-pancreas transplant unit. Transplantation. 2014;97(6):654–9.
Hope WW, Schmelzer TM, Newcomb WL, Heath JJ, Lincourt AE, Norton HJ, Heniford BT, Iannitti DA. Guidelines for power and time variables for microwave ablation in an in vivo porcine kidney. J Surg Res. 2009;153(2):263–7.
Lubner MG, Brace CL, Hinshaw JL, Lee FT Jr. Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol. 2010;21(8 Suppl):S192–203.
Moore C, Salas N, Zaias J, Shields J, Bird V, Leveillee R. Effects of microwave ablation of the kidney. J Endourol. 2010;24(3):439–44.
Wells SA, Wheeler KM, Mithqal A, Patel MS, Brace CL, Schenkman NS. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment. Abdom Radiol (NY). 2016;41(6):1203–11.
Yu J, Liang P, Yu XL, Cheng ZG, Han ZY, Mu MJ, Wang XH. US-guided percutaneous microwave ablation of renal cell carcinoma: intermediate-term results. Radiology. 2012;263(3):900–8.
Funding
This study was not supported by any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Human and Animal Rights
Treatments and procedures described in this study were in accordance with the ethical standards of the institutional committee at which it was conducted (Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Consent for Publication
Consent for publication was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Favi, E., Raiteri, M., Paone, G. et al. Microwave Ablation of Renal Cell Carcinoma of the Transplanted Kidney: Two Cases. Cardiovasc Intervent Radiol 42, 1653–1657 (2019). https://doi.org/10.1007/s00270-019-02302-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-019-02302-w